Literature DB >> 2667495

Proliferative activity and steroid receptors determined by immunohistochemistry in adjacent frozen sections of 102 breast carcinomas.

M L Helin1, M J Helle, H J Helin, J J Isola.   

Abstract

Adjacent frozen sections of 102 consecutive female breast carcinomas were examined for the expression of the Ki-67 antibody-reactive proliferation-associated nuclear antigen and of estrogen and progesterone receptors with the use of monoclonal antibodies and peroxidase histochemistry. The results of steroid receptor stainings were semiquantitatively assessed (histoscore) on the basis of nuclear staining intensity and the percentage of positively stained carcinoma cell nuclei. Carcinomas negative for either receptor had significantly higher percentages of Ki-67-positive cells. The highest percentages of Ki-67-positive cells were observed in carcinomas negative for both estrogen and progesterone receptors. There was a highly significant decrease in receptor histoscores with increasing proliferative cell fractions as determined by Ki-67 positivity. No significant (progesterone receptor) or poor negative correlation (estrogen receptor) was observed when proliferative cell fractions were related to receptor concentrations from conventional steroid-binding assays. Immunoperoxidase staining for the Ki-67 antibody-defined proliferation antigen and steroid receptors in tissue sections provides a simple means to gain information of therapeutic and prognostic importance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667495

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.

Authors:  S A Swanson; J J Brooks
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.

Authors:  Tetsuya Tsujikawa; Yoshio Yoshida; Yasushi Kiyono; Tetsuji Kurokawa; Takashi Kudo; Yasuhisa Fujibayashi; Fumikazu Kotsuji; Hidehiko Okazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-18       Impact factor: 9.236

3.  Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.

Authors:  Lusheng Xu; Yeon-Jin Kwon; Natalya Frolova; Adam D Steg; Kun Yuan; Martin R Johnson; William E Grizzle; Renee A Desmond; Andra R Frost
Journal:  Breast Cancer Res Treat       Date:  2009-11-10       Impact factor: 4.872

4.  Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer.

Authors:  V Jensen; M Ladekarl
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

5.  Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis.

Authors:  M Rudas; M F Gnant; M Mittlböck; R Neumayer; A Kummer; R Jakesz; G Reiner; A Reiner
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

Authors:  R B Clarke; I J Laidlaw; L J Jones; A Howell; E Anderson
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

7.  Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Authors:  Grazia Arpino; Valerie J Bardou; Gary M Clark; Richard M Elledge
Journal:  Breast Cancer Res       Date:  2004-02-17       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.